- Home
- ICHR vs MDXG Comparison
ICHR vs MDXG Comparison
Compare ICHR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICHR
- MDXG
- Stock Information
- Founded
- ICHR 1999
- MDXG 2006
- Country
- ICHR United States
- MDXG United States
- Employees
- ICHR N/A
- MDXG N/A
- Industry
- ICHR Semiconductors
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- ICHR Technology
- MDXG Health Care
- Exchange
- ICHR Nasdaq
- MDXG Nasdaq
- Market Cap
- ICHR 1.0B
- MDXG 1.1B
- IPO Year
- ICHR 2016
- MDXG N/A
- Fundamental
- Price
- ICHR $30.84
- MDXG $9.12
- Analyst Decision
- ICHR Strong Buy
- MDXG Strong Buy
- Analyst Count
- ICHR 8
- MDXG 5
- Target Price
- ICHR $42.50
- MDXG $12.00
- AVG Volume (30 Days)
- ICHR 225.6K
- MDXG 674.7K
- Earning Date
- ICHR 02-04-2025
- MDXG 02-26-2025
- Dividend Yield
- ICHR N/A
- MDXG N/A
- EPS Growth
- ICHR N/A
- MDXG N/A
- EPS
- ICHR N/A
- MDXG 0.52
- Revenue
- ICHR $819,230,000.00
- MDXG $342,804,000.00
- Revenue This Year
- ICHR $5.99
- MDXG $9.56
- Revenue Next Year
- ICHR $15.26
- MDXG $9.19
- P/E Ratio
- ICHR N/A
- MDXG $18.12
- Revenue Growth
- ICHR N/A
- MDXG 10.93
- 52 Week Low
- ICHR $26.40
- MDXG $5.47
- 52 Week High
- ICHR $46.43
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- ICHR 45.10
- MDXG 53.35
- Support Level
- ICHR $29.64
- MDXG $8.50
- Resistance Level
- ICHR $33.23
- MDXG $9.71
- Average True Range (ATR)
- ICHR 1.32
- MDXG 0.30
- MACD
- ICHR -0.13
- MDXG -0.04
- Stochastic Oscillator
- ICHR 24.57
- MDXG 51.24
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.